Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Zeitlinger

Showing results (1-10 of 352) with videos related to

Pageof 36
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 11, 2024
Advances in infectious disease treatments-innovations and regulatory pathways against emerging challengesMarkus Zeitlinger
The Lancet. Infectious Diseases|March 28, 2018
Extended infusion-putting the benefit into contextMarkus Zeitlinger
The Lancet. Infectious Diseases|July 27, 2019
A pragmatic trial in bone and joint infectionMarkus Zeitlinger
European Journal of Clinical Pharmacology|June 26, 2021
EACPT Virtual Meeting 2021Markus Zeitlinger
Current Clinical Pharmacology|September 6, 2012
Methods to measure target site penetration of antibiotics in critically ill patientsRichard Schwameis, Markus Zeitlinger
Expert Review of Clinical Pharmacology|April 14, 2021
Pharmacological and clinical profile of cefiderocol, a siderophore cephalosporin against gram-negative pathogensAnselm Jorda, Markus Zeitlinger
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 10, 2024
Preclinical and clinical studies in the drug development process of European Medicines Agency-approved non-HIV antiviral agents: a narrative reviewLena Pracher, Markus Zeitlinger
Clinical Pharmacokinetics|November 16, 2023
Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antifungal Agents: A ReviewTheresa Pecho, Markus Zeitlinger
The Journal of Antimicrobial Chemotherapy|March 6, 2026
Experimental biofilm models for pharmacokinetic and pharmacodynamic investigations: bridging in vitro, ex vivo and in vivo systemsStephanie Supparitsch, Markus Zeitlinger
Lancet (London, England)|May 10, 2026
Zoliflodacin: non-inferior, but not equivalent?Anselm Jorda, Markus Zeitlinger
Pageof 36

Showing results (1-10 of 352) with videos related to

Sort By:
Pageof 36
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 11, 2024
Advances in infectious disease treatments-innovations and regulatory pathways against emerging challengesMarkus Zeitlinger
The Lancet. Infectious Diseases|March 28, 2018
Extended infusion-putting the benefit into contextMarkus Zeitlinger
The Lancet. Infectious Diseases|July 27, 2019
A pragmatic trial in bone and joint infectionMarkus Zeitlinger
European Journal of Clinical Pharmacology|June 26, 2021
EACPT Virtual Meeting 2021Markus Zeitlinger
Current Clinical Pharmacology|September 6, 2012
Methods to measure target site penetration of antibiotics in critically ill patientsRichard Schwameis, Markus Zeitlinger
Expert Review of Clinical Pharmacology|April 14, 2021
Pharmacological and clinical profile of cefiderocol, a siderophore cephalosporin against gram-negative pathogensAnselm Jorda, Markus Zeitlinger
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 10, 2024
Preclinical and clinical studies in the drug development process of European Medicines Agency-approved non-HIV antiviral agents: a narrative reviewLena Pracher, Markus Zeitlinger
Clinical Pharmacokinetics|November 16, 2023
Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antifungal Agents: A ReviewTheresa Pecho, Markus Zeitlinger
The Journal of Antimicrobial Chemotherapy|March 6, 2026
Experimental biofilm models for pharmacokinetic and pharmacodynamic investigations: bridging in vitro, ex vivo and in vivo systemsStephanie Supparitsch, Markus Zeitlinger
Lancet (London, England)|May 10, 2026
Zoliflodacin: non-inferior, but not equivalent?Anselm Jorda, Markus Zeitlinger
Pageof 36